LM11A-31 or C31

Summarized from “Alzheimer’s From A New Angle” by Alice Park, originally printed in Time Magazine.

A new drug called LM11A-31 or C31 as it’s known to its researcher Dr. Frank Longo from Stanford University School of Medicine is being tested right now in clinical trials. This drug is attacking the Alzheimer’s dilemma from a new angle. Instead of trying to dissolve the harmful proteins, amyloid plaques and tau protein tangles, he is using this nerve growth factor to bolster the brain neurons in order to help protect them from the damaging protein onslaught.

Continue Reading →